Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Haematologica|February 25, 2021
Clinical spectrum, outcome and management of immune thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemiaVincent Jachiet, Guillaume Moulis, Jérome Hadjadj, et al.Arthritis Care & Research|July 13, 2026
Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS-DAI)Kevin Byram, Heřman Mann, Danielle Hammond, et al.American Journal of Hematology|January 8, 2026
Real-World Effectiveness and Safety of Fostamatinib in Difficult-to-Treat Immune Thrombocytopenia Patients. A Prospective, Multicenter Registry in FranceGuillaume Moulis, Matthieu Mahévas, Jean-François Viallard, et al.Arthritis & Rheumatology (Hoboken, N.J.)|September 22, 2025
Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter StudyTali Eviatar, Dafne Capelusnik, Corrado Campochiaro, et al.The Lancet. Haematology|December 12, 2018
Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational studyNicolas Delanoy, Jean-Marie Michot, Thibault Comont, et al.Blood|October 30, 2024
Long-term follow-up of the STOPAGO studyAdrien Cottu, Stéphanie Guillet, Jean-François Viallard, et al.Blood|September 2, 2022
Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort studyStéphanie Guillet, Valentine Loustau, Emmanuelle Boutin, et al.Blood|March 9, 2023
Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter studyStéphanie Guillet, Etienne Crickx, Imane Azzaoui, et al.Annals of the Rheumatic Diseases|December 10, 2023
Serious infections in patients with VEXAS syndrome: data from the French VEXAS registryBenjamin de Valence, Marion Delaune, Yann Nguyen, et al.American Journal of Hematology|July 19, 2025
Cold Agglutinin Syndrome Secondary to Mycoplasma pneumoniae Infection in Adults: Results From a Large French Observational Study (MyCOLD Study)Kevin Chevalier, Matthieu Holub, Romain Palich, et al.Pageof 5